Martin Brenner - Chief Executive Officer and Chief Scientific Officer at iBio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer and Chief Scientific Officer
Stock Symbol
IBIO on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Martin Brenner - trading volume in the past year for iBio, Inc.

Holdings reported by Martin Brenner for iBio, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 182,502 $48.5 K $0.27 Nov 1, 2023 Direct
Stock Option (right to buy) 110,000 May 9, 2024 Direct Common Stock

Transactions reported by Martin Brenner for iBio, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership